The U.S. Food and Drug Administration recently granted marketing authorization for an anterior cruciate ligament (ACL) implant, intended to perform as an alternative to traditional ACL reconstructions. The Bridge-Enhanced ACL Repair (BEAR) Implant, by Miach Orthopaedics, differs from the traditional surgical reconstruction as it does not require the use of harvested tendons for ACL repair
Register to receive a free U.S. Soft Tissue Reinforcement and Regeneration Devices Market Report Suite synopsis and brochure Ortho RTi has recently announced the initiation of a pivotal animal study for the Ortho-R device designed for rotator cuff repair. The study is intended to have a 6-month duration. Furthermore, a pre-Investigational New Drug meeting with the U.S.
Register to receive a free U.S. Soft Tissue Reinforcement and Regeneration Devices Market Report Suite synopsis and brochure International medical market research and consulting firm, iData Research, has released their procedure volume analysis for one of the most commonly performed surgical procedures in the United States: hernia repair. There are many different types of hernias, including inguinal,
Register to receive a free Soft Tissue Reinforcement and Regeneration Market Report Suite for EU 2018-2024 synopsis and brochure iData Research, a global leader in medical device market research, announced the release of a new study on the European market for soft tissue reinforcement and regeneration. This market analysis looks closely into the main driver, the increasing demographic
Register to receive a free Soft Tissue Reinforcement and Regeneration Market for Europe 2018-2024 report synopsis and brochure Scientists from the University of Sheffield have developed a material that could be used as an alternative to the current vaginal mesh material, polypropylene, used to treat pelvic organ prolapse and stress urinary incontinence. The use of these current
Register to receive a free Soft Tissue Reinforcement and Regeneration Devices Market Report Suite for US 2017-2023 synopsis and brochure MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing proprietary human placental tissue allografts, today announced that it successfully settled the Company’s longstanding patent infringement lawsuit against Musculoskeletal Transplant Foundation, Inc.
TELA Bio’s OviTex Reinforced BioScaffold (RBS) products are a distinct class of surgical implants that integrate biologic and synthetic materials in a unique embroidered construction that allows free movement of fluid and cells through the construct.
Breast Reconstruction Awareness Day is a collaborative effort between the American Society of Plastic Surgeons (ASPS), The Plastic Surgery Foundation (The PSF), plastic surgeons specializing in breast surgery, nurse navigators, corporate partners, breast cancer support groups and organizations.
The market for hernia repair has grown due to the general increase in hernia incidence in the United States. The U.S. market for soft tissue reinforcement and regeneration is expected to grow by nearly 8% by 2021.
